Cargando…
An evaluation of adverse events following an immunization campaign with the live, attenuated SA14-14-2 Japanese encephalitis vaccine in Cambodia
INTRODUCTION: Japanese encephalitis (JE) virus is the most common cause of vaccine-preventable encephalitis in Asia. The SA14-14-2 JE vaccine manufactured by Chengdu Institute of Biological Products has been shown to be safe and effective in clinical trials and childhood routine immunization program...
Autores principales: | Hills, Susan L., Soeung, Sann Chan, Sarath, Svay, Morn, Chheng, Dara, Cheam, Fischer, Marc, Thigpen, Michael C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9182652/ https://www.ncbi.nlm.nih.gov/pubmed/35679297 http://dx.doi.org/10.1371/journal.pone.0269480 |
Ejemplares similares
-
Improving community coverage of Japanese encephalitis vaccination: lessons learned from a mass campaign in Battambang Province, Cambodia
por: Thigpen, Michael C., et al.
Publicado: (2022) -
Evaluation of Immunization Knowledge, Practices, and Service-delivery in the Private Sector in Cambodia
por: Soeung, Sann Chan, et al.
Publicado: (2008) -
Chimeric Japanese Encephalitis Virus SA14/SA14-14-2 Was Virulence Attenuated and Protected the Challenge of Wild-Type Strain SA14
por: Huang, Rong, et al.
Publicado: (2019) -
Updated estimation of the impact of a Japanese encephalitis immunization program with live, attenuated SA 14-14-2 vaccine in Nepal
por: Upreti, Shyam Raj, et al.
Publicado: (2017) -
Effectiveness of the SA 14-14-2 Live-Attenuated Japanese Encephalitis Vaccine in Myanmar
por: Ngwe Tun, Mya Myat, et al.
Publicado: (2021)